Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Catherine H Smith

Showing results (21-30 of 169) with videos related to

Pageof 17
Sort By:
Pharmacoeconomics|December 21, 2014
Biological therapies for the treatment of severe psoriasis in patients with previous exposure to biological therapy: a cost-effectiveness analysisLaura M Sawyer, David Wonderling, Karina Jackson, et al.
The Journal of Dermatological Treatment|August 3, 2010
The value of monitoring ciclosporin concentration 2 hours post-dose (C2) in dermatology: a prospective cohort studyAi-Lean Chew, Saqib J Bashir, Atholl Johnston, et al.
American Journal of Perinatology|March 3, 2020
Randomized Controlled Trials of Headache Treatments in Pregnancy: A Systematic ReviewElisa T Bushman, Gabriella Cozzi, Rachel G Sinkey, et al.
Acta Dermato-Venereologica|January 24, 2020
Psoriasis and GeneticsNick Dand, Satveer K Mahil, Francesca Capon, et al.
The British Journal of Dermatology|March 17, 2023
Neutropenia in patients on dupilumab for atopic dermatitis: a case series and review of trial dataPirunthan Pathmarajah, Roberto Corso, Amr Salam, et al.
Annals of the Rheumatic Diseases|November 3, 2017
Risk of uveitis and inflammatory bowel disease in people with psoriatic arthritis: a population-based cohort studyRachel Charlton, Amelia Green, Gavin Shaddick, et al.
The Lancet. Rheumatology|September 7, 2025
Development and validation of a prognostic model for predicting the risk of allopurinol-induced severe cutaneous adverse reactions: a retrospective new-user cohort study using linked primary care, hospitalisation, and mortality dataEdoardo Cipolletta, Georgina Nakafero, Davide Rozza, et al.
The Journal of Investigative Dermatology|April 6, 2007
Polymorphisms in folate, pyrimidine, and purine metabolism are associated with efficacy and toxicity of methotrexate in psoriasisEmanuela Campalani, Monica Arenas, Anthony M Marinaki, et al.
JAMA Dermatology|June 4, 2025
Adalimumab Monotherapy vs Adalimumab With Methotrexate for PsoriasisZenas Z N Yiu, Catherine H Smith, Philip Laws, et al.
Seminars in Arthritis and Rheumatism|July 17, 2022
Telemedicine in rheumatology care: A systematic reviewLesley E Jackson, Timothy A Edgil, Brittany Hill, et al.
Pageof 17

Showing results (21-30 of 169) with videos related to

Sort By:
Pageof 17
Pharmacoeconomics|December 21, 2014
Biological therapies for the treatment of severe psoriasis in patients with previous exposure to biological therapy: a cost-effectiveness analysisLaura M Sawyer, David Wonderling, Karina Jackson, et al.
The Journal of Dermatological Treatment|August 3, 2010
The value of monitoring ciclosporin concentration 2 hours post-dose (C2) in dermatology: a prospective cohort studyAi-Lean Chew, Saqib J Bashir, Atholl Johnston, et al.
American Journal of Perinatology|March 3, 2020
Randomized Controlled Trials of Headache Treatments in Pregnancy: A Systematic ReviewElisa T Bushman, Gabriella Cozzi, Rachel G Sinkey, et al.
Acta Dermato-Venereologica|January 24, 2020
Psoriasis and GeneticsNick Dand, Satveer K Mahil, Francesca Capon, et al.
The British Journal of Dermatology|March 17, 2023
Neutropenia in patients on dupilumab for atopic dermatitis: a case series and review of trial dataPirunthan Pathmarajah, Roberto Corso, Amr Salam, et al.
Annals of the Rheumatic Diseases|November 3, 2017
Risk of uveitis and inflammatory bowel disease in people with psoriatic arthritis: a population-based cohort studyRachel Charlton, Amelia Green, Gavin Shaddick, et al.
The Lancet. Rheumatology|September 7, 2025
Development and validation of a prognostic model for predicting the risk of allopurinol-induced severe cutaneous adverse reactions: a retrospective new-user cohort study using linked primary care, hospitalisation, and mortality dataEdoardo Cipolletta, Georgina Nakafero, Davide Rozza, et al.
The Journal of Investigative Dermatology|April 6, 2007
Polymorphisms in folate, pyrimidine, and purine metabolism are associated with efficacy and toxicity of methotrexate in psoriasisEmanuela Campalani, Monica Arenas, Anthony M Marinaki, et al.
JAMA Dermatology|June 4, 2025
Adalimumab Monotherapy vs Adalimumab With Methotrexate for PsoriasisZenas Z N Yiu, Catherine H Smith, Philip Laws, et al.
Seminars in Arthritis and Rheumatism|July 17, 2022
Telemedicine in rheumatology care: A systematic reviewLesley E Jackson, Timothy A Edgil, Brittany Hill, et al.
Pageof 17